Pfizer's New COVID-19 Booster Targets Omicron Variant, Offers Extra Protection for Kids

The FDA has authorized Pfizer-BioNTech's bivalent COVID-19 vaccine for children aged 6 months to 4 years. The booster showed greater effectiveness against COVID-19 hospitalization.

Related Keywords

North Carolina ,United States ,Peter Marks ,Pfizer ,Carolina Police ,Drug Administration ,Getty Images ,Biologics Evaluation ,North Carolina Police Rescues ,Year Old After Being Lured ,Social Media ,Minneapolis Bus Driver Goes Above ,Beyond To Help Lost ,Year Old Boy During ,Fda ,Covid 19 ,Ovid 19 Omicron Booster Vaccine For Kids ,Bivalent ,Ids Under Five ,